window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-108383172-1');

About Sander Hagemans

This author has not yet filled in any details.
So far Sander Hagemans has created 2 blog entries.

Novigenix AI to Present Clinical Data at AACR 2026 Linking Immuno-Pharmacodynamics to Radioligand Therapy Response

By |2026-04-14T13:25:20+02:0014 April 2026|News Novigenix, Press Releases|

Marks First In-Human Clinical Study Demonstrating the Value of Immuno-Pharmacodynamics in the Assessment of Radioligand Therapy  Novigenix AI Liquid Biopsy Platform Identifies Immune Activation Patterns Associated with Radioligand Therapy Response in Gastroenteropancreatic Neuroendocrine Tumors Epalinges, Switzerland — April 14, 2026  — Novigenix AI, a leader in AI-driven healthcare solutions, today announced the presentation of

Read More

Novigenix AI Spin-Out to Accelerate AI-Powered Immune Intelligence

By |2026-03-30T12:15:25+02:006 March 2026|Communiqué de presse, Communiqué de presse, Communiqué de presse, Communiqué de presse, News Novigenix, News Novigenix, News Novigenix|

Epalinges, Switzerland, March 5, 2026 – Novigenix SA, a leader in immunotranscriptomic diagnostics, today announced the formal spin-out and launch of Novigenix AI, a new precision medicine company dedicated to transforming therapy development through AI-powered immune intelligence. A Strategic Separation to Unlock Two High-Growth Markets The new AI spin-out separates Novigenix's colorectal cancer (CRC)

Read More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Learn more Ok

Privacy Notice

Go to Top